30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Healthcare Equipment & Supplies

OraSure Technologies Inc (OSUR)

Track

Over the last 90 days, OraSure Technologies Inc. has seen a net insider buying value of $224,750, with 3 insiders making net purchases. Notably, Steven Kyle Boyd made multiple buy transactions totaling $224,750. Executive net buying was $0. The stock has experienced a 26.2% price increase over the past 90 days.
Stock chart
Ticker: OSUR Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Boyd Steven Kyle
1 purchase — total 74,750 USD
Buy 14 May 2026
Value US$4,341,839.83 | Price 245.44 | Shares 16,897
Buy 13 May 2026
Value US$3,733,260.56 | Price 448.16 | Shares 972
Buy 12 May 2026
Value US$74,500.00 | Price 2.98 | Shares 25,000
Planned buy 20 Mar 2026
Value US$94,597.01 | Price 2.93 | Shares 32,300
Planned buy 20 Mar 2026
Value US$94,600.24 | Price 2.93 | Shares 32,300
Planned buy 13 Mar 2026
Value US$66,029.97 | Price 3.00 | Shares 22,021
Planned buy 13 Mar 2026
Value US$66,032.97 | Price 3.00 | Shares 22,022
Proposed sale 4 Dec 2025
Value US$225,000.00 | Price 2.51 | Shares 89,716
Buy 28 Nov 2025
Value US$4,981.83 | Price 2.37 | Shares 2,100
Buy 28 Feb 2025
Value US$100,026.76 | Price 3.49 | Shares 28,670
Buy 27 Feb 2025
Value US$39,270.00 | Price 3.08 | Shares 12,750
Buy 27 Feb 2025
Value US$247,377.84 | Price 3.15 | Shares 78,625
Buy 27 Feb 2025
Value US$201,683.20 | Price 3.15 | Shares 64,000
Buy 27 Feb 2025
Value US$151,217.24 | Price 3.17 | Shares 47,659
Buy 27 Feb 2025
Value US$21,420.00 | Price 3.06 | Shares 7,000
Planned sale 19 Dec 2023
Value US$194,219.15 | Price 8.05 | Shares 24,129
Proposed sale 19 Dec 2023
Value US$194,219.64 | Price 8.05 | Shares 24,129
Sale 15 Aug 2023
Value US$11,427.00 | Price 6.50 | Shares 1,758
Proposed sale 15 Aug 2023
Value US$11,427.00 | Price 6.50 | Shares 1,758
Buy 30 May 2023
Value US$492,810.00 | Price 4.93 | Shares 100,000
Buy 26 Aug 2022
Value US$200,000.00 | Price 4.00 | Shares 50,000
Buy 25 Aug 2022
Value US$25,137.60 | Price 4.19 | Shares 6,000
Buy 17 Aug 2022
Value US$9,657.78 | Price 4.39 | Shares 2,200
Buy 12 Aug 2022
Value US$53,916.00 | Price 4.49 | Shares 12,000
Planned sale 23 Dec 2020
Value US$117,600.00 | Price 11.76 | Shares 10,000
Buy 14 May 2019
Value US$8,560.00 | Price 8.56 | Shares 1,000
Buy 13 May 2019
Value US$74,273.85 | Price 8.55 | Shares 8,687
Buy 13 May 2019
Value US$11,213.02 | Price 8.54 | Shares 1,313
Buy 10 May 2019
Value US$3,663.00 | Price 9.00 | Shares 407
Buy 10 May 2019
Value US$6,321.00 | Price 9.03 | Shares 700
Buy 10 May 2019
Value US$10,824.00 | Price 9.02 | Shares 1,200
Buy 10 May 2019
Value US$11,713.00 | Price 9.01 | Shares 1,300
Buy 10 May 2019
Value US$57,792.72 | Price 9.04 | Shares 6,393
Sale 1 Apr 2019
Value US$185,015.37 | Price 11.10 | Shares 16,667
Sale 27 Aug 2018
Value US$130,320.00 | Price 16.29 | Shares 8,000
Sale 16 Feb 2018
Value US$180,010.00 | Price 18.00 | Shares 10,000
Sale 15 Feb 2018
Value US$419,247.34 | Price 17.97 | Shares 23,333
Sale 15 Feb 2018
Value US$179,450.00 | Price 17.95 | Shares 10,000
Buy 7 Nov 2017
Value US$71,163.50 | Price 14.23 | Shares 5,000
Planned sale 4 Oct 2017
Value US$527,229.00 | Price 23.00 | Shares 22,923
Planned sale 29 Sep 2017
Value US$563,712.50 | Price 22.55 | Shares 25,000
Sale 31 Aug 2017
Value US$2,040.00 | Price 20.40 | Shares 100
Sale 31 Aug 2017
Value US$184,475.64 | Price 20.47 | Shares 9,012
Sale 30 Aug 2017
Value US$20,110.00 | Price 20.11 | Shares 1,000
Sale 22 Aug 2017
Value US$22,704.00 | Price 21.12 | Shares 1,075
Sale 22 Aug 2017
Value US$42,160.00 | Price 21.08 | Shares 2,000
Sale 7 Aug 2017
Value US$1,550,296.24 | Price 21.26 | Shares 72,916
Sale 7 Aug 2017
Value US$202,365.92 | Price 21.03 | Shares 9,623
Sale 7 Aug 2017
Value US$1,323,281.90 | Price 20.73 | Shares 63,840
Sale 7 Aug 2017
Value US$3,751,674.62 | Price 21.29 | Shares 176,197
Sale 7 Aug 2017
Value US$319,800.00 | Price 21.32 | Shares 15,000
Sale 4 Aug 2017
Value US$6,785,753.85 | Price 20.32 | Shares 333,915
Sale 4 Aug 2017
Value US$949,567.33 | Price 20.22 | Shares 46,959
Planned sale 27 Jun 2017
Value US$1,457,817.02 | Price 16.28 | Shares 89,541
Planned sale 27 Jun 2017
Value US$1,250,475.00 | Price 16.67 | Shares 75,000
Planned sale 27 Jun 2017
Value US$2,157,969.88 | Price 17.13 | Shares 125,954
Sale 31 May 2017
Value US$752,890.00 | Price 15.06 | Shares 50,000
Sale 30 May 2017
Value US$225,975.00 | Price 15.07 | Shares 15,000
Sale 30 May 2017
Value US$100,989.90 | Price 15.15 | Shares 6,666
Sale 26 May 2017
Value US$1,100,394.06 | Price 14.73 | Shares 74,684
Sale 10 May 2017
Value US$1,690,845.00 | Price 14.70 | Shares 115,000
Sale 9 May 2017
Value US$3,149,098.00 | Price 15.01 | Shares 209,800
Sale 8 May 2017
Value US$2,533,852.44 | Price 15.09 | Shares 167,916
Sale 8 May 2017
Value US$1,203,246.42 | Price 15.09 | Shares 79,738
Sale 8 May 2017
Value US$97,695.00 | Price 15.03 | Shares 6,500
Sale 8 May 2017
Value US$25,470.00 | Price 15.00 | Shares 1,698
Sale 8 May 2017
Value US$79,530.00 | Price 15.00 | Shares 5,302
Sale 5 May 2017
Value US$1,710,243.72 | Price 15.06 | Shares 113,562
Sale 5 May 2017
Value US$990,960.00 | Price 15.00 | Shares 66,064
Sale 5 May 2017
Value US$2,098,863.02 | Price 14.93 | Shares 140,552
Sale 5 May 2017
Value US$11,145.20 | Price 14.96 | Shares 745
Sale 5 May 2017
Value US$138,454.80 | Price 14.96 | Shares 9,255
Sale 5 May 2017
Value US$672,181.90 | Price 14.95 | Shares 44,962
Sale 5 May 2017
Value US$445,018.69 | Price 15.13 | Shares 29,413
Planned sale 21 Mar 2017
Value US$2,640.00 | Price 12.00 | Shares 220
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-05-14 2026-05-14 B Purchase
Boyd Steven Kyle
Non-Executive Director
16,897 +33.5%
245.44
US$4,341,840 		16,897 +33.5% 245.44 US$4,341,840
2026-05-14 2026-05-13 B Purchase
Boyd Steven Kyle
Non-Executive Director
972 -9.4%
448.16
US$3,733,261 		972 -9.4% 448.16 US$3,733,261
2026-05-14 2026-05-12 B Purchase
Boyd Steven Kyle
Non-Executive Director
95,557 +22.3%
440.69
US$137,610 		95,557 +22.3% 440.69 US$137,610
2026-03-23 2026-03-20 PP Planned purchase
1.8
EGLINTON MANNER CARRIE

President & CEO

Executive Director
32,300 +1.5%
2.93
US$94,597 		32,300 +1.5% 2.93 US$94,597
2026-03-23 2026-03-20 PP Planned purchase
3.3
McGrath Kenneth J

Chief Financial Officer

Officer
32,300 +5.8%
2.93
US$94,600 		32,300 +5.8% 2.93 US$94,600
2026-03-16 2026-03-13 PP Planned purchase
3.3
McGrath Kenneth J

Chief Financial Officer

Officer
22,021 +4.1%
3.00
US$66,030 		22,021 +4.1% 3.00 US$66,030
2026-03-16 2026-03-13 PP Planned purchase
1.8
EGLINTON MANNER CARRIE

President & CEO

Executive Director
22,022 +1.0%
3.00
US$66,033 		22,022 +1.0% 3.00 US$66,033
2025-12-04 2025-12-04 PrS Proposed sale
2.2
Mara Aspinall

Board
89,716
2.51
US$225,000 		89,716 2.51 US$225,000
2025-12-02 2025-11-28 B Purchase
2.8
Gagliano Nancy J
Non-Executive Director
2,100 +1.3%
2.37
US$4,982 		2,100 +1.3% 2.37 US$4,982
2025-03-03 2025-02-28 B Purchase
1.8
EGLINTON MANNER CARRIE

President & CEO

Executive Director
28,670 +2.3%
3.49
US$100,027 		28,670 +2.3% 3.49 US$100,027
2025-03-03 2025-02-27 B Purchase
2.8
Gagliano Nancy J
Non-Executive Director
12,750 +16.2%
3.08
US$39,270 		12,750 +16.2% 3.08 US$39,270
2025-02-27 2025-02-27 B Purchase
1.8
EGLINTON MANNER CARRIE

President & CEO

Executive Director
78,625 +6.7%
3.15
US$247,378 		78,625 +6.7% 3.15 US$247,378
2025-02-27 2025-02-27 B Purchase
3.3
McGrath Kenneth J

Chief Financial Officer

Officer
64,000 +20.8%
3.15
US$201,683 		64,000 +20.8% 3.15 US$201,683
2025-02-27 2025-02-27 B Purchase
3.5
Kenny John P.
Non-Executive Director
47,659 +204.9%
3.17
US$151,217 		47,659 +204.9% 3.17 US$151,217
2025-02-27 2025-02-27 B Purchase
1.7
Marmora Lelio
Non-Executive Director
7,000 +11.5%
3.06
US$21,420 		7,000 +11.5% 3.06 US$21,420
2023-12-21 2023-12-19 PlS Planned sale
Weber Kathleen Gallagher

Chief Product Officer

Officer
24,129 -8.7%
8.05
US$194,219 		24,129 -8.7% 8.05 US$194,219
2023-12-19 2023-12-19 PrS Proposed sale
Weber Kathleen Gallagher

Officer

Officer
24,129
8.05
US$194,220 		24,129 8.05 US$194,220
2023-08-17 2023-08-15 S Sale
1.7
Anthony Michele Marie

SVP Finance & CAO

Officer
1,758 -2.0%
6.50
US$11,427 		1,758 -2.0% 6.50 US$11,427
2023-08-15 2023-08-15 PrS Proposed sale
1.7
Anthony Michele Marie

Officer

Officer
1,758
6.50
US$11,427 		1,758 6.50 US$11,427
2023-05-31 2023-05-30 B Purchase
3.3
McGrath Kenneth J

Chief Financial Officer

Officer
100,000 +53.9%
4.93
US$492,810 		100,000 +53.9% 4.93 US$492,810
2022-08-29 2022-08-26 B Purchase
2.3
LANCASTER RONNY B
Non-Executive Director
50,000 +91.3%
4.00
US$200,000 		50,000 +91.3% 4.00 US$200,000
2022-08-31 2022-08-25 B Purchase
2.2
Aspinall Mara G.
Non-Executive Director
6,000 +8.4%
4.19
US$25,138 		6,000 +8.4% 4.19 US$25,138
2022-08-22 2022-08-17 B Purchase
2.8
Gagliano Nancy J
Non-Executive Director
2,200 +5.5%
4.39
US$9,658 		2,200 +5.5% 4.39 US$9,658
2022-08-16 2022-08-12 B Purchase
3.6
Celano Michael
Non-Executive Director
12,000 +12.0%
4.49
US$53,916 		12,000 +12.0% 4.49 US$53,916
2021-01-04 2020-12-23 PlS Planned sale
Weber Kathleen Gallagher

EVP & BU Lead - Molecular

Officer
10,000 -9.4%
11.76
US$117,600 		10,000 -9.4% 11.76 US$117,600
2019-05-14 2019-05-14 B Purchase
3.4
TANG STEPHEN S PHD

President and CEO
1,000 +0.8%
8.56
US$8,560 		1,000 +0.8% 8.56 US$8,560
2019-05-14 2019-05-13 B Purchase
0.9
JERRETT JACK E

SVP & General Counsel
8,687 +10.4%
8.55
US$74,274 		8,687 +10.4% 8.55 US$74,274
2019-05-14 2019-05-13 B Purchase
0.9
JERRETT JACK E

SVP & General Counsel
1,313 +1.6%
8.54
US$11,213 		1,313 +1.6% 8.54 US$11,213
2019-05-14 2019-05-10 B Purchase
3.3
Cuca Roberto

CFO
407 +0.9%
9.00
US$3,663 		407 +0.9% 9.00 US$3,663
2019-05-14 2019-05-10 B Purchase
3.3
Cuca Roberto

CFO
700 +1.5%
9.03
US$6,321 		700 +1.5% 9.03 US$6,321
2019-05-14 2019-05-10 B Purchase
3.3
Cuca Roberto

CFO
1,200 +2.7%
9.02
US$10,824 		1,200 +2.7% 9.02 US$10,824
2019-05-14 2019-05-10 B Purchase
3.3
Cuca Roberto

CFO
1,300 +3.0%
9.01
US$11,713 		1,300 +3.0% 9.01 US$11,713
2019-05-14 2019-05-10 B Purchase
3.3
Cuca Roberto

CFO
6,393 +17.0%
9.04
US$57,793 		6,393 +17.0% 9.04 US$57,793
2019-04-03 2019-04-01 S Sale
3.4
TANG STEPHEN S PHD

President and CEO
16,667 -12.3%
11.10
US$185,015 		16,667 -12.3% 11.10 US$185,015
2018-08-29 2018-08-27 S Sale Patrick Charles W Non-Executive Director
8,000 -12.8%
16.29
US$130,320 		8,000 -12.8% 16.29 US$130,320
2018-02-20 2018-02-16 S Sale SMITH BRIAN

EVP & BU Lead - Molecular

Officer
10,000 -35.6%
18.00
US$180,010 		10,000 -35.6% 18.00 US$180,010
2018-02-20 2018-02-15 S Sale TANG STEPHEN S PHD Non-Executive Director
23,333 -39.1%
17.97
US$419,247 		23,333 -39.1% 17.97 US$419,247
2018-02-20 2018-02-15 S Sale SMITH BRIAN

EVP & BU Lead - Molecular

Officer
10,000 -35.6%
17.95
US$179,450 		10,000 -35.6% 17.95 US$179,450
2017-11-09 2017-11-07 B Purchase Aspinall Mara G.
5,000 +inf%
14.23
US$71,164 		5,000 +inf% 14.23 US$71,164
2017-10-06 2017-10-04 PlS Planned sale Michels Douglas A

President & CEO

Executive Director
22,923 -3.1%
23.00
US$527,229 		22,923 -3.1% 23.00 US$527,229
2017-10-03 2017-09-29 PlS Planned sale Michels Douglas A

President & CEO

Executive Director
25,000 -3.3%
22.55
US$563,712 		25,000 -3.3% 22.55 US$563,712
2017-09-05 2017-08-31 S Sale SMITH BRIAN

See Remarks
100 -0.4%
20.40
US$2,040 		100 -0.4% 20.40 US$2,040
2017-09-05 2017-08-31 S Sale SMITH BRIAN

See Remarks
9,012 -27.7%
20.47
US$184,476 		9,012 -27.7% 20.47 US$184,476
2017-08-31 2017-08-30 S Sale Patrick Charles W
1,000 -1.9%
20.11
US$20,110 		1,000 -1.9% 20.11 US$20,110
2017-08-24 2017-08-22 S Sale SMITH BRIAN

SEE REMARKS
1,075 -4.4%
21.12
US$22,704 		1,075 -4.4% 21.12 US$22,704
2017-08-24 2017-08-22 S Sale SMITH BRIAN

SEE REMARKS
2,000 -7.5%
21.08
US$42,160 		2,000 -7.5% 21.08 US$42,160
2017-08-09 2017-08-07 S Sale Zezzo II Anthony

EVP - Infectious Diseases
72,916 -33.4%
21.26
US$1,550,296 		72,916 -33.4% 21.26 US$1,550,296
2017-08-08 2017-08-07 S Sale JERRETT JACK E

SVP & General Counsel
9,623 -16.4%
21.03
US$202,366 		9,623 -16.4% 21.03 US$202,366
2017-08-08 2017-08-07 S Sale JERRETT JACK E

SVP & General Counsel
63,840 -52.0%
20.73
US$1,323,282 		63,840 -52.0% 20.73 US$1,323,282
2017-08-08 2017-08-07 S Sale SPAIR RONALD H

COO & CFO

Executive Director
176,197 -61.8%
21.29
US$3,751,675 		176,197 -61.8% 21.29 US$3,751,675
2017-08-08 2017-08-07 S Sale KUNA MARK L

SVP & Controller
15,000 -23.6%
21.32
US$319,800 		15,000 -23.6% 21.32 US$319,800
2017-08-08 2017-08-04 S Sale SPAIR RONALD H

COO & CFO

Executive Director
333,915 -75.4%
20.32
US$6,785,754 		333,915 -75.4% 20.32 US$6,785,754
2017-08-08 2017-08-04 S Sale KUNA MARK L

SVP & Controller
46,959 -42.5%
20.22
US$949,567 		46,959 -42.5% 20.22 US$949,567
2017-06-29 2017-06-27 PlS Planned sale Michels Douglas A

President & CEO

Executive Director
89,541 -10.4%
16.28
US$1,457,817 		89,541 -10.4% 16.28 US$1,457,817
2017-06-29 2017-06-27 PlS Planned sale Michels Douglas A

President & CEO

Executive Director
75,000 -8.0%
16.67
US$1,250,475 		75,000 -8.0% 16.67 US$1,250,475
2017-06-29 2017-06-27 PlS Planned sale Michels Douglas A

President & CEO

Executive Director
125,954 -11.9%
17.13
US$2,157,970 		125,954 -11.9% 17.13 US$2,157,970
2017-06-02 2017-05-31 S Sale SPAIR RONALD H

COO & CFO

Executive Director
50,000 -31.4%
15.06
US$752,890 		50,000 -31.4% 15.06 US$752,890
2017-05-30 2017-05-30 S Sale LANCASTER RONNY B Non-Executive Director
15,000 -70.4%
15.07
US$225,975 		15,000 -70.4% 15.07 US$225,975
2017-05-30 2017-05-30 S Sale Patrick Charles W Non-Executive Director
6,666 -11.3%
15.15
US$100,990 		6,666 -11.3% 15.15 US$100,990
2017-05-30 2017-05-26 S Sale LANCASTER RONNY B Non-Executive Director
74,684 -92.2%
14.73
US$1,100,394 		74,684 -92.2% 14.73 US$1,100,394
2017-05-11 2017-05-10 S Sale Zezzo II Anthony

EVP, Marketing and Sales

Officer
115,000 -44.2%
14.70
US$1,690,845 		115,000 -44.2% 14.70 US$1,690,845
2017-05-11 2017-05-09 S Sale Michels Douglas A

President & CEO

Executive Director
209,800 -21.5%
15.01
US$3,149,098 		209,800 -21.5% 15.01 US$3,149,098
2017-05-09 2017-05-08 S Sale Michels Douglas A

President & CEO

Executive Director
167,916 -17.9%
15.09
US$2,533,852 		167,916 -17.9% 15.09 US$2,533,852
2017-05-09 2017-05-08 S Sale Michels Douglas A

President & CEO

Executive Director
79,738 -9.4%
15.09
US$1,203,246 		79,738 -9.4% 15.09 US$1,203,246
2017-05-09 2017-05-08 S Sale SPAIR RONALD H

COO & CFO

Executive Director
6,500 -5.6%
15.03
US$97,695 		6,500 -5.6% 15.03 US$97,695
2017-05-09 2017-05-08 S Sale KUNA MARK L

SVP & Controller

Officer
1,698 -2.6%
15.00
US$25,470 		1,698 -2.6% 15.00 US$25,470
2017-05-09 2017-05-08 S Sale KUNA MARK L

SVP & Controller

Officer
5,302 -7.7%
15.00
US$79,530 		5,302 -7.7% 15.00 US$79,530
2017-05-09 2017-05-05 S Sale Michels Douglas A

President & CEO

Executive Director
113,562 -12.9%
15.06
US$1,710,244 		113,562 -12.9% 15.06 US$1,710,244
2017-05-09 2017-05-05 S Sale SPAIR RONALD H

COO & CFO

Executive Director
66,064 -37.7%
15.00
US$990,960 		66,064 -37.7% 15.00 US$990,960
2017-05-09 2017-05-05 S Sale PRINGLE ROGER L Non-Executive Director
140,552 -64.8%
14.93
US$2,098,863 		140,552 -64.8% 14.93 US$2,098,863
2017-05-09 2017-05-05 S Sale Patrick Charles W Non-Executive Director
745 -1.3%
14.96
US$11,145 		745 -1.3% 14.96 US$11,145
2017-05-09 2017-05-05 S Sale Patrick Charles W Non-Executive Director
9,255 -100.0%
14.96
US$138,455 		9,255 -100.0% 14.96 US$138,455
2017-05-09 2017-05-05 S Sale Celano Michael Non-Executive Director
44,962 -54.1%
14.95
US$672,182 		44,962 -54.1% 14.95 US$672,182
2017-05-09 2017-05-05 S Sale KUNA MARK L

SVP & Controller

Officer
29,413 -31.7%
15.13
US$445,019 		29,413 -31.7% 15.13 US$445,019
2017-03-23 2017-03-21 PlS Planned sale TANG STEPHEN S PHD Non-Executive Director
220 -0.7%
12.00
US$2,640 		220 -0.7% 12.00 US$2,640
Explore more

More insider trading research around OraSure Technologies Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Healthcare Services companies with insider activity
More Healthcare Equipment & Supplies companies with insider activity
Insider trading in North America